First Description of Seronegative HTLV-1 Carriers in Argentina
Authors:
- Sandra GallegoSGSandra Gallego
- María C. FrutosMFMaría C. Frutos
- Sebastián BlancoSBSebastián Blanco
- Gonzalo CastroGCGonzalo Castro
- Marcos BalangeroMBMarcos Balangero
- David Elías PanigoDPDavid Elías Panigo
- Arnaldo MangeaudAMArnaldo Mangeaud
- Carlos RemondeguiCRCarlos Remondegui
- Anderson Santos RochaARAnderson Santos Rocha
- Gabriela Melo FrancoGFGabriela Melo Franco
- Marina Lobato MartinsMMMarina Lobato Martins
- Edel Figueiredo Barbosa-StancioliEBEdel Figueiredo Barbosa-Stancioli
Open Access
- 1 April 2020
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 102 (4) , 889-895
Abstract
In some areas of Argentina endemic for human T-lymphotropic virus type 1 (HTLV-1), tropical spastic paraparesis is frequent in subjects who lack antibodies against the virus; however, the relevance of this seronegative status in the country has not been investigated. In neighboring countries, HTLV-1 seronegative status has been described in patients with different diseases; however, data regarding features of seronegative HTLV-1 carriers are scarce. We investigated the seronegative status in 124 relatives of 28 HTLV-1 infected subjects from an endemic area in Northwest Argentina. Blood samples and clinical/epidemiological data were collected. Human T-lymphotropic virus type 1 infection was diagnosed by serology and long terminal repeat (LTR) sequence, env and tax gene detection. IgG anti-Tax HTLV-1 antibody, tax gene sequence, and DNA proviral load were also evaluated. Seventy-five percent of the 124 relatives were negative for HTLV-1/2 antibodies; 35.5% were also negative by molecular assays and 64.5% were negative for HTLV-1 LTR and env sequences, but positive for two sequences of HTLV-1 tax gene. Also, 35.7% of these subjects had IgG anti-Tax antibodies. The seronegative HTLV-1 status was significantly associated with male gender, youth, and sensory symptoms/autonomic nervous system dysfunction. High rates of seronegative symptomatic and asymptomatic HTLV-1 carriers in Argentina are described. The evidence highlights that HTLV-1 prevalence may be underestimated worldwide. Larger cohort studies are required to assess disease outcome in these seronegative subjects. Also, the findings emphasize the limitations of ongoing screening assays for diagnosis and blood safety. Therefore, algorithms for HTLV-1 diagnosis should include not only serological but also molecular assays.Keywords
This publication has 30 references indexed in Scilit:
- Epidemiological Aspects and World Distribution of HTLV-1 InfectionFrontiers in Microbiology, 2012
- Prevalence of human T-Cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in South ChileJournal of Medical Virology, 2011
- Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral loadJournal of Clinical Virology, 2011
- Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathyNeurology, 2009
- Mycosis fungoides in European Russia: No Antibodies to Human T Cell Leukemia Virus Type I Structural Proteins, but Virus-Like Sequences in Blood and SalivaIntervirology, 2005
- Adult T‐cell leukemia with cyclic neutropenia in a seronegative patient carrying only the tax gene of HTLV‐IAmerican Journal of Hematology, 2002
- Phylogenetic Subgroups of Human T Cell Lymphotropic Virus (HTLV) Type I in thetaxGene and Their Association with Different Risks for HTLV‐I–Associated Myelopathy/Tropical Spastic ParaparesisThe Journal of Infectious Diseases, 2000
- Kinetics Study of Human Retrovirus Antigens Expression in T Lymphocytic Cell Lines by Indirect Immunofluorescence AssayViral Immunology, 1997
- The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirsJournal of General Virology, 1996
- Spastic Paraparesis in a Patient Carrying Defective Human T Cell Leukemia Virus Type I (HTLV-I) Provirus Sequences but Lacking a Humoral or Cytotoxic T Cell Response to HTLV-IThe Journal of Infectious Diseases, 1994